FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208260296> ?p ?o ?g. }

• W3208260296 endingPage "e292" @default.
• W3208260296 startingPage "e292" @default.
• W3208260296 abstract "<h3>Purpose/Objective(s)</h3> A phase I/II study combining nivolumab with androgen deprivation therapy (ADT) and high dose brachytherapy (HDR) followed by external beam radiotherapy (EBRT) indicated that the regimen is well tolerated and effective with radiographic and pathologic evidence of increased antitumor activity. In the present study we sought to utilize MR-based imaging characteristics to define parameters of antitumor response to HDR+EBRT and nivolumab in patients with Grade Group (GG) 5 prostate cancer. <h3>Materials/Methods</h3> Eligible patients received ADT in combination with nivolumab and HDR followed by EBRT delivered using MR-guided radiotherapy. Data from 12 patients were analyzed using MRI from diagnosis, once-weekly treatment from fractions 5, 10, 15 and 25 and 3-month follow up. Images were fused and analyzed using an image analysis package. At time of enrollment the dominant tumor (ROI) was contoured and tracked at different timepoints. The change in T2 value was assessed using voxel data at diagnosis and follow up. The delta (δ) of average change was estimated between partial and complete responders from diagnosis and follow up. The same analysis was done on the treatment MR using steady-state coherent sequences. All data were normalized against the prostate values. <h3>Results</h3> Median follow up was 17 months. Complete radiographic response (CR) was seen in 6 out of 12 patients. A δ T2 was estimated between baseline and follow up T2 tumor ROI. Partial responders had higher δ of 62.5 as compared to complete responders with δ of 28. When compared longitudinally over 5 fractions, on average change in steady-state coherent sequence over time was higher in partial responders than complete responders. <h3>Conclusion</h3> Our preliminary results show a greater δ in T2 signal in partial responders consistent with continued tumor response on weekly imaging, while complete responders showed minimal change over time. This finding suggests that CR may derive a rapid and early response to nivolumab, ADT and HDR than the partial responders. Furthermore, tracking δ in T2 signal and steady-state coherent sequences may be a reliable tool for defining tumor response in real-time and needs further validation in a larger cohort. This study was registered under NCT03543189." @default.
• W3208260296 created "2021-11-08" @default.
• W3208260296 creator A5002733008 @default.
• W3208260296 creator A5005227259 @default.
• W3208260296 creator A5008484013 @default.
• W3208260296 creator A5008914481 @default.
• W3208260296 creator A5009931242 @default.
• W3208260296 creator A5035397040 @default.
• W3208260296 creator A5047495544 @default.
• W3208260296 creator A5060238737 @default.
• W3208260296 date "2021-11-01" @default.
• W3208260296 modified "2023-09-27" @default.
• W3208260296 title "Defining MR-Based Parameters of Treatment Response to Immune-Modulatory Therapy for Grade Group 5 Prostate Cancer" @default.
• W3208260296 doi "https://doi.org/10.1016/j.ijrobp.2021.07.927" @default.
• W3208260296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34701110" @default.
• W3208260296 hasPublicationYear "2021" @default.
• W3208260296 type Work @default.
• W3208260296 sameAs 3208260296 @default.
• W3208260296 citedByCount "0" @default.
• W3208260296 crossrefType "journal-article" @default.
• W3208260296 hasAuthorship W3208260296A5002733008 @default.
• W3208260296 hasAuthorship W3208260296A5005227259 @default.
• W3208260296 hasAuthorship W3208260296A5008484013 @default.
• W3208260296 hasAuthorship W3208260296A5008914481 @default.
• W3208260296 hasAuthorship W3208260296A5009931242 @default.
• W3208260296 hasAuthorship W3208260296A5035397040 @default.
• W3208260296 hasAuthorship W3208260296A5047495544 @default.
• W3208260296 hasAuthorship W3208260296A5060238737 @default.
• W3208260296 hasBestOaLocation W32082602961 @default.
• W3208260296 hasConcept C121608353 @default.
• W3208260296 hasConcept C126322002 @default.
• W3208260296 hasConcept C126838900 @default.
• W3208260296 hasConcept C126894567 @default.
• W3208260296 hasConcept C143998085 @default.
• W3208260296 hasConcept C2775908122 @default.
• W3208260296 hasConcept C2776235491 @default.
• W3208260296 hasConcept C2777416452 @default.
• W3208260296 hasConcept C2777899217 @default.
• W3208260296 hasConcept C2780192828 @default.
• W3208260296 hasConcept C2781413609 @default.
• W3208260296 hasConcept C2989005 @default.
• W3208260296 hasConcept C509974204 @default.
• W3208260296 hasConcept C71924100 @default.
• W3208260296 hasConceptScore W3208260296C121608353 @default.
• W3208260296 hasConceptScore W3208260296C126322002 @default.
• W3208260296 hasConceptScore W3208260296C126838900 @default.
• W3208260296 hasConceptScore W3208260296C126894567 @default.
• W3208260296 hasConceptScore W3208260296C143998085 @default.
• W3208260296 hasConceptScore W3208260296C2775908122 @default.
• W3208260296 hasConceptScore W3208260296C2776235491 @default.
• W3208260296 hasConceptScore W3208260296C2777416452 @default.
• W3208260296 hasConceptScore W3208260296C2777899217 @default.
• W3208260296 hasConceptScore W3208260296C2780192828 @default.
• W3208260296 hasConceptScore W3208260296C2781413609 @default.
• W3208260296 hasConceptScore W3208260296C2989005 @default.
• W3208260296 hasConceptScore W3208260296C509974204 @default.
• W3208260296 hasConceptScore W3208260296C71924100 @default.
• W3208260296 hasIssue "3" @default.
• W3208260296 hasLocation W32082602961 @default.
• W3208260296 hasLocation W32082602962 @default.
• W3208260296 hasOpenAccess W3208260296 @default.
• W3208260296 hasPrimaryLocation W32082602961 @default.
• W3208260296 hasRelatedWork W1977071394 @default.
• W3208260296 hasRelatedWork W2030798726 @default.
• W3208260296 hasRelatedWork W2085529113 @default.
• W3208260296 hasRelatedWork W2087149288 @default.
• W3208260296 hasRelatedWork W2138863125 @default.
• W3208260296 hasRelatedWork W2597301728 @default.
• W3208260296 hasRelatedWork W2761204422 @default.
• W3208260296 hasRelatedWork W2789553788 @default.
• W3208260296 hasRelatedWork W2946095553 @default.
• W3208260296 hasRelatedWork W3193431922 @default.
• W3208260296 hasVolume "111" @default.
• W3208260296 isParatext "false" @default.
• W3208260296 isRetracted "false" @default.
• W3208260296 magId "3208260296" @default.
• W3208260296 workType "article" @default.